| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 402.91M | 608.08M | 612.78M | 538.36M | 534.28M |
| Gross Profit | 4.35M | 8.70M | 44.54M | 56.14M | 71.90M |
| EBITDA | -92.03M | -16.52M | 51.24M | 50.67M | 62.15M |
| Net Income | -105.41M | -32.40M | 30.58M | 28.79M | 60.61M |
Balance Sheet | |||||
| Total Assets | 345.07M | 466.06M | 490.50M | 444.75M | 428.98M |
| Cash, Cash Equivalents and Short-Term Investments | 665.00K | 13.41M | 24.55M | 32.37M | 56.68M |
| Total Debt | 65.42M | 54.98M | 49.41M | 51.86M | 43.73M |
| Total Liabilities | 92.11M | 107.69M | 96.82M | 84.56M | 97.57M |
| Stockholders Equity | 252.96M | 358.37M | 393.69M | 360.19M | 331.40M |
Cash Flow | |||||
| Free Cash Flow | -16.47M | -14.57M | -3.09M | -32.20M | -120.18M |
| Operating Cash Flow | -16.47M | -14.57M | -3.09M | -24.36M | -75.25M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | -7.84M | -44.93M |
| Financing Cash Flow | 3.72M | 3.43M | -4.73M | 7.90M | 133.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$2.20B | 3.90 | 16.17% | 12.15% | -3.66% | 4.32% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
49 Neutral | HK$650.36M | -0.30 | -118.41% | ― | -3.72% | 21.15% | |
46 Neutral | HK$328.54M | 2.01 | -6.00% | 7.35% | 24.69% | -257.79% | |
46 Neutral | HK$300.46M | -0.25 | -11.32% | ― | -8.54% | -25.17% | |
44 Neutral | HK$393.60M | -28.18 | -32.47% | ― | -8.31% | -56.88% |